U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07046884) titled 'Improving Personalized Treatment in Oncology: Effects of Integrated Oncological Decision-making' on Sept. 30, 2024.
Brief Summary: The research aims to evaluate an Integrated Oncological Decision-making Model (IODM) to tailor oncological treatment plans to individual patients. The primary objective is to assess the impact of the IODM on personalized decision-making and patient outcomes. The study will employ a stepped-wedge cluster randomized trial design involving eight oncological care paths across four medical centers in the Netherlands. The study population consists of 400 adult patients (50 per care path) who will undergo treatm...